← Back to Search

Behavioural Intervention

Intervention group for Systemic Scleroderma

N/A

Recruiting

Led By Janet L Poole

Research Sponsored by University of New Mexico

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 5 weeks, 12 weeks, 24 weeks

Awards & highlights

Study Summary

This trial is testing an online program called Making it Work Systemic Sclerosis to see if it helps people with Systemic Sclerosis stay employed and feel more confident at work. Participants will either receive the

Who is the study for?

This trial is for individuals with Systemic Sclerosis who are currently employed. Participants should be interested in an online program aimed at helping them stay in the workforce and manage work-related challenges.Check my eligibility

What is being tested?

The 'Making it Work Systemic Sclerosis' online intervention program is being tested to see if it can help participants remain employed and boost their confidence in handling work issues. The study compares immediate participation with a delayed (wait list) group.See study design

What are the potential side effects?

Since this is a non-medical, educational intervention involving questionnaires and meetings with professionals, there are no direct medical side effects expected from participating.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 5 weeks, 12 weeks, 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 5 weeks, 12 weeks, 24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 5 weeks, 12 weeks, 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Job Related Self-efficacy Scale

Job Self-Efficacy Scale

Secondary outcome measures

The Work Instability Scale

Work Productivity and Activity Impairment Questionnaire Specific Health Problem Subscale

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention groupExperimental Treatment1 Intervention

Complete questionnaires Attend one 2 hour weekly virtual meeting for 5 weeks and an individual meeting with an occupational therapist and with a vocational counselor

Group II: control groupActive Control1 Intervention

Complete questionnaires

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor

372 Previous Clinical Trials

3,528,739 Total Patients Enrolled

Janet L PoolePrincipal InvestigatorUniversity of New Mexico

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals above the age of 40 being sought for enrollment in this research study?

"This research study is enrolling participants who have surpassed their 18th birthday but are not yet past the age of 67."

Answered by AI

Is the enrollment for this study currently open?

"Yes, as per clinicaltrials.gov data, this investigation is actively seeking participants. The initial posting of the trial was on 12th August 2023 and the latest update was on 28th March 2024. The study aims to recruit a total of 50 individuals from one designated site."

Answered by AI

How many participants are currently undergoing treatment in this medical study?

"Indeed, the details on clinicaltrials.gov reveal that recruitment for this investigation is ongoing. The study was initially published on December 8th, 2023 and last modified on March 28th, 2024. Enrollment targets to include 50 participants from a single site."

Answered by AI

Do I meet the necessary requirements to participate in this clinical investigation?

"Candidates eligible for participation in this medical research must have a diagnosis of systemic scleroderma and fall within the age range of 18 to 67 years. The trial aims to enroll approximately 50 qualified participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Making it Work Program for Systemic Sclerosis

2023. "Making it Work Program for Systemic Sclerosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06338722.

All > Scleroderma Research Foundation > Scleroderma